Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenytoin auto-induction

M Chetty1, R Miller, M A Seymour

  • 1Department of Experimental and Clinical Pharmacology, University of Witwatersrand, Johannesburg, South Africa.

Therapeutic Drug Monitoring
|March 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the gap between omics research and dental practice.

BDJ open·2024
Same author

The association between cytology and histopathology in thyroid nodules over a 6-year period in an urban hospital in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2023
Same author

Case report: Enamel renal syndrome: a case series from sub-Saharan Africa.

Frontiers in oral health·2023
Same author

Indwelling pleural catheters: an overview and real-life experience.

QJM : monthly journal of the Association of Physicians·2019
Same author

Dentinogenesis imperfecta in Osteogenesis imperfecta type XI in South Africa: a genotype-phenotype correlation.

BDJ open·2019
Same author

Hereditary dentine dysplasias: terminology in the context of osteogenesis imperfecta.

British dental journal·2016
Same journal

Mass Spectrometric Characterization of Flucloxacillin Binding to Serum Albumin in Hospitalized Patients With Hypoalbuminemia: An Observational Pilot Study.

Therapeutic drug monitoring·2026
Same journal

Therapeutic Drug Monitoring-Driven Prediction of Cyclosporine-Associated Liver Injury in Pediatric Thalassemia After Hematopoietic Stem Cell Transplantation.

Therapeutic drug monitoring·2026
Same journal

Donor-derived Cell-free DNA Does Not Improve the Detection of Acute Kidney Allograft Rejection Beyond Urinary CXCL9 and CXCL10.

Therapeutic drug monitoring·2026
Same journal

A Novel Dosing Strategy for Tacrolimus in Lung Transplant Recipients: Integrating Machine Learning with Population Pharmacokinetic Analysis.

Therapeutic drug monitoring·2026
Same journal

Recommendations for Assessing Methodological Quality in Systematic Reviews of Population Pharmacokinetic Models: A Systematic Review.

Therapeutic drug monitoring·2026
Same journal

Wide-Range Quantification of Belumosudil in Patients with Chronic Graft-Versus-Host Disease by High-Performance Liquid Chromatography.

Therapeutic drug monitoring·2026
See all related articles

Phenytoin auto-induction was investigated in a crossover study. Results indicate that repeated phenytoin doses lead to lower drug concentrations, suggesting enhanced elimination due to enzyme induction.

Area of Science:

  • Pharmacokinetics
  • Drug Metabolism
  • Clinical Pharmacology

Background:

  • Information on phenytoin auto-induction is limited and contradictory.
  • Understanding auto-induction is crucial for optimizing phenytoin therapy and research.
  • Phenytoin is an antiepileptic drug with a narrow therapeutic index.

Purpose of the Study:

  • To investigate the presence and extent of phenytoin auto-induction.
  • To assess the impact of repeated phenytoin dosing on drug exposure.
  • To clarify the implications for phenytoin pharmacotherapy.

Main Methods:

  • An open-label, randomized, three-way crossover study involving 18 healthy volunteers.
  • Volunteers received three different phenytoin formulations in a random sequence.

Related Experiment Videos

  • Period effects were analyzed to evaluate prior phenytoin exposure's influence on area under the concentration-time curve (AUC).

    • Main Results:

    • The ratio of AUC(o-t) for the third dose versus the first dose was 81.19% (90% CI: 74.37%–88.00%).
    • The ratio of AUC(o-infinity) for the third dose versus the first dose was 76.25% (90% CI: 65.3%–87.2%).
    • Both AUC(o-t) and AUC(o-infinity) were significantly smaller after the third dose compared to the first dose.

    Conclusions:

    • The study suggests that phenytoin exhibits auto-induction.
    • Enhanced elimination of phenytoin, likely due to enzyme induction, occurs with repeated dosing.
    • These findings have significant implications for managing phenytoin therapy and drug interactions.